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Aim: Deep vein thrombosis (DVT) and pulmonary thromboembolism (PE) are important causes 
of morbidity and mortality in medically ill patients. This study was done to assess risk factors 
and prophylaxis given for DVT and PE in newly admitted medically ill patients during the first 
two weeks of their hospital stay at a tertiary care center hospital in India.
Methods: All patients within one week of their admission in intensive care unit (ICU) and 
wards were enrolled in the study after an informed written consent. Patients who had DVT 
prophylaxis within the past month or any contraindications for DVT prophylaxis were excluded. 
A structured proforma was designed and effective risk stratification for DVT was done. Patients 
were followed for up to two weeks to record any changes in the risk categories and document 
any signs of PE or DVT if present. Any prophylaxis given for DVT or PE was noted.
Results: Seventy-five percent of patients had the highest risk for DVT and PE. Only 12.5% 
had DVT prophylaxis within the first two days of admission. Within two weeks of admission, 
30.8% of patients were discharged, and 16.2% died. 72.6% of the patients still in the wards 
belonged to the highest risk category. Clinical signs and symptoms of DVT and PE were 
present in 25.8% and 9.8% of patients, respectively after the second week of admission. 86% of 
symptomatic patients belonged to the highest risk category initially and none of them received 
any prophylaxis. 21.6% of the highest risk category patients died within two weeks of their 
admission. A statistically significant correlation was found between mortality and risk score of 
the patients for DVT and between lack of prophylaxis and mortality (p  0.05).
Conclusion: A significant risk for DVT and PE exists in medically ill patients, but only a small 
proportion of the patients are given prophylaxis. This study underlines the need to aggressively 
implement DVT risk stratification strategy in medical patients and provide prophylaxis unless 
contraindicated.
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Introduction
Venous thromboembolism (VTE), which includes deep vein thrombosis (DVT) and 
pulmonary embolism (PE), is an important cause of morbidity and mortality in critically 
ill patients.1 Incidence of symptomatic DVT or PE or any other complication related 
to venous thromboembolism in critically ill patients not receiving any prophylaxis is 
3.6% in western hospitals and it contributes significantly to the health care cost.2
In developing countries such as India, a significant prevalence of etiological risk fac-
tors for DVT and prothrombotic factors has been shown amongst hospitalized patients.3 Vascular Health and Risk Management 2009:5 644
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Studies have shown a need of DVT prophylaxis in 95% 
of intensive care unit (ICU) patients in India with signifi-
cant underuse of prophylaxis in only 55% of the high risk 
patients.4 Another study in Indian population has shown a 
overall incidence of confirm DVTs to be 17.46 per hundred 
thousand patients with 64% being nonsurgical nontrauma 
patients.5
Critically ill patients are at increased risk of VTE due 
to predisposing premorbid conditions, occurrence of sepsis, 
trauma, and post-admission events.6 Individual identification 
of suspected DVT and PE cases could be a difficult task and 
many cases could be missed. However, blanket prophylaxis 
of all admitted patients may not be cost-effective, especially 
in a developing country such as India.7 Thus primary 
prevention of VTE with risk assessment and stratification for 
DVT and subsequent antithrombotic prophylaxis in moderate 
to severe risk category patients is the most rational means of 
reducing mortality and morbidity.
The American College of Chest Physicians (ACCP) 
developed guidelines for the use of low molecular weight 
heparins (LMWH) and unfractionated heparins (UFH) in the 
prevention of VTEs in patients with acute illnesses.8 However 
the use of DVT prophylaxis in hospitalized medical patients 
still remains suboptimal, around 15%–16%.9
This is an observational study done to evaluate and 
assess the risk factors and prophylaxis given for DVT 
and PE in patients admitted in medical wards and ICU 
during the first two weeks of their hospital stay using 
Caprini’s risk stratification score card10 at a tertiary care 
center hospital in India. We looked into the prevalence 
of risk factors for DVT and PE in these patients within 
one week of their admission and the interventions done 
by health care professionals to prevent their occurrence 
in these patients.
Methods
This is a prospective observational study done in the 
medicine ICU and wards at the All India Institute of 
Medical Sciences, a tertiary health care center in north 
India. The study did not affect patient care. Health 
care providers were not aware that this study was being 
conducted. All patients within one week of their admission 
in the medicine ward or ICU were enrolled in the study 
after written informed consent. Patients who had been on 
DVT prophylaxis within one month of their admission and 
those who had absolute or relative contraindications for 
DVT prophylaxis such as gastrointestinal bleeding, history 
of intracranial bleed, severe bleeding disorder, severe 
thrombocytopenia, recent neurosurgery, or liver cirrhosis 
were excluded from the study. A structured proforma was 
designed for risk assessment and stratification of DVT in 
critically ill patients using a previously published standard 
protocol (Caprini’s risk stratification score card).10 The risk 
factors for DVT used in this protocol to stratify patients are 
similar to that published by ACCP and the International 
Union of Angiology (IUAS) consensus statement and has 
been used previously for DVT risk assessment alongside 
ACCP and IUAS risk score models in other studies 
done in developing countries.11 The risk assessment 
and stratification scorecard used is shown in Figure 1. 
Demographic data including patient’s age, sex, and body 
weight were collected. Other baseline information like 
admitting diagnosis, any invasive instrumentation like 
ventilator, venous catheters, etc were also noted down. 
Effective risk stratification for DVT was done in low, 
moderate, high, and highest categories according to the 
patients DVT risk score at their time of admission as 
shown in Figure 1.
Patients were followed up for over two weeks from 
their day of admission. Any change in the patients’ general 
morbidity status and their DVT risk profile was recorded. 
Patients were examined for any clinical signs and symptoms 
of DVT or PE (Table 1). Any prophylaxis given and relevant 
investigations for DVT (D-dimer, Doppler ultrasound, high 
resolution chest computed tomography [CT], pulmonary 
angiography) that was done during this time interval was also 
noted. The data was analyzed using SPSS software (v. 12; 
SPSS Inc., Chicago, IL, USA).
Results
One hundred fifty patients were approached for our study 
within one week of their admission. Of these, 13 (8.67%) 
patients refused consent, 16 (10.67%) had one or more 
contraindications for DVT, 4 (2.67%) had DVT prophylaxis 
in the past three months. Finally, 117 patients were 
enrolled in the study. Of these, 68 (58.11%) were in the 
wards and 49 (41.89%) were in the ICU. Table 2 shows 
the demographic distribution of the patients in the study. 
Baseline clinical characteristics of the patients are shown in 
Table 3. We observed that 75% (100% ICU; 57.5% ward) 
of patients on their initial visit had the highest risk for DVT 
and PE according to the Caprini’s risk stratification score 
card.10 Detailed risk category distribution of the patients 
during the first visit is shown in Table 4. Respiratory system 
involvement was seen in 41.8% of patients while sepsis 
and septicemia or other infectious etiologies were seen in Vascular Health and Risk Management 2009:5 645
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25.6% of patients. Cardiovascular system involvement was 
seen in 17.1% of patients. Multiple system involvement was 
seen in many patients. Primary respiratory system involve-
ment was found in 35.5% of patients who had highest risk 
for DVT. Sepsis and septicemia was seen in 25.6% of 
patients with highest risk for DVT. Cardiovascular system 
involvement was seen in 16.2% of cases with the highest 
risk for DVT.
On follow up 16.2% (22.4% ICU; 11.7% ward) of 
patients died and 30.7% (14.3% ICU; 42.6% ward) of 
patients got discharged within two weeks of their admission. 
Of the remaining 62 patients that were still in hospital after 
two weeks of admission, 72% (96.6% ICU; 48.8% ward) of 
patients had the highest risk for DVT and PE. 90% of patients 
who had highest risk for the DVT and PE after two weeks 
initially also belonged to the highest risk category. Thus only 
a minor fraction, 10% of admitted patients, had progressive 
increase in their risk scoring for DVT. Two or more signs 
and symptoms of DVT and PE were seen in 35.5% (22 of 62) 
of the patients that were still in hospital after two weeks in 
hospital. 86.6% (19 of 22) of these symptomatic patients 
initially belonged to the highest risk category.
DVT prophylaxis was started within first two days of 
admission in only 12.5% (11of 88) of patients who belonged 
to the highest risk category for DVT and PE initially. None 
of the patients belonging to moderate or high risk catego-
ries received any prophylaxis. All the DVT prophylaxis 
administered was in form of LMWH. Pneumatic compres-
sions or electric stockings or any other form of mechanical 
Figure 1 Score card used for effective DVT risk stratification of the subjects.
Abbreviations: cHF, chronic heart failure; cOPD, chronic obstructive pulmonary disease; DVT, deep vein thrombosis; HRT, hormone replacement therapy; iBD, irritable 
bowel disease; OcP, oral contraceptive pill.
A (each item represents one risk score)
C (each item represents three risk scores)
B (each item represents two risk scores)
D (each item represents five risk scores)
Minor surgery planned
Age 41−60 years
Age >60 years
History of prior major surgery <1 month
Pregnancy or postpartum <1 month
Varicose veins
IBD
OCP/HRT
Obesity
Swollen legs
History of DVT
MI
CHF
COPD
Malignancy or chemotherapy
Immobilized plaster cast
Bed ridden for >72 hours
Central venous accesses
Stroke
H/O thrombosis
Age >75 years
Severe sepsis or infection
Abnormal pulmonary function
Respiratory assistance
Myeloproliferative disorder
Congential or acquired thrombophilia
Multiple trauma
Acute spinal injury
Total score Risk category
0
1
2
3−4
>5
No risk
Low risk
High risk
Highest risk
Moderate risk
Table 1 signs and symptoms of DVT and Pe that were looked for 
in the subject patients
signs and symptoms of DVT
•  Pain or tenderness in the leg
•  swelling of the leg or along a vein in the leg
•  Red or discolored skin on the leg
•    increased warmth in the area of the leg that’s swollen or is in pain
signs and symptoms of Pe
•  Unexplained shortness of breath
•  Pain with deep breathing
•  coughing up blood
•  Rapid breathing and fast heart rate
Abbreviations: DVT, deep vein thrombosis; Pe, pulmonary embolism.Vascular Health and Risk Management 2009:5 646
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DVT prophylaxis were not used in any patients. No major 
complications from DVT prophylaxis such as severe bleed-
ing or thrombocytopenia developed in any of the patients 
who received anticoagulation. None of the symptomatic 
patients had received any prophylaxis for DVT during 
course of their admission. 59.1% (n = 13) of the symptom-
atic patients had one or more relevant investigations for 
DVT or PE. These investigations included D-dimer levels, 
ultrasound Doppler of the lower limbs, high resolution CT 
scan of the chest. 22.7% (n = 5) of the symptomatic patients 
for DVT or PE were documented to have DVT (three by 
Doppler ultrasound) or PE (two by high resolution CT 
scan) by investigators. 21.6% (n = 19) of the highest risk 
category patients died within one week of follow-up and 
none of these patients received any prophylaxis for DVT. 
A statistically significant correlation was found between 
the mortality and risk scoring of the patients (p  0.05). 
Also we found a statistically significant correlation between 
lack of DVT (p  0.05) prophylaxis and mortality in our 
subjects.
Discussion
The study shows that a significant percentage of admissions 
in medical wards and ICU are subject to very high risk of 
DVT and PE starting from the early days of hospital stay. 
However there is a serious lack of effective prophylaxis for 
the same in these patients. Our study found that only a minor 
fraction of the patients who belonged to highest risk category 
got prophylaxis for DVT.
In our health care set up DVT has traditionally been 
recognized as a complication of long-term hospitaliza-
tion in medically ill patients and is often ignored in the 
initial few days of admission. Similar results have been 
shown in past studies done in India and other developing 
countries. In Brazil, DVT prophylaxis risk assessment 
using Caprini’s score card also showed a significant 
underutilization of DVT prophylaxis.11 Our study high-
lights that a significant proportion of patients have 
increased risks for DVT even during the first few days 
of admission, which, if overlooked, could be responsible 
for life-threatening complications at the later stages. Early 
recognition of these risk factors and prompt prophylaxis 
in high-risk cases can be really effective in preventing 
these life-threatening complications. ACCP has laid 
down clear guidelines on DVT prophylaxis in medically 
ill patients.8 We found a lack of implementation of any 
DVT prophylaxis strategy among acutely ill patients in 
the first two weeks of their management in our institu-
tion with only ∼11% of the highest risk patients getting 
DVT prophylaxis. None of the moderate to high risk 
patients in our study got any prophylaxis for VTE. Several 
studies done in the West have also shown an underuse of 
DVT prophylaxis in hospitalized medical patients despite 
ACCP recommendations.8,9,12–14
Table 3 Baseline clinical characteristics of the patients
Baseline characteristics No. of subjects (%)
Primary etiology
•  Respiratory 49 (41.8%)
•      sepsis, septicemia, and other 
infectious disease
30 (25.6%)
•  cardiovascular 20 (17.1%)
•  Diabetes 20 (17.1%)
•  cancer 8 (6.8%)
•  Others 17 (14.5%)
invasive instrumentations 66 (56.4%)
Mean heart rate  98 ± 18
Mean systolic blood pressure 123.3 ± 17.6 mmHg
Mean diastolic blood pressure 78.8 ± 12.2 mmHg
sensorium
conscious  71 (60.7%)
Unconscious  36 (30.8%)
Altered sensorium  10 (8.5%)
Notes: *More than one system involvement was seen in many patients.
Table 4 Risk categorization of the patients of DVT risk during 
their initial visit
Ward (n = 68) icU (n = 49)
no risk 6 (8.8%) 0 (0%)
Low risk 6 (8.8%) 0 (0%)
Moderate risk 8 (11.7%) 0 (0%)
High risk 9 (13.2%) 0 (0%)
Highest risk 39 (57.5%) 49 (100%)
Abbreviations: DVT, deep vein thrombosis; icU, intensive care unit.
Table 2 Demographic details of the patients
Total no. of patients 117
no. of ward patients 68 (58.11%)
no. of icU patients 49 (41.89%)
no. of males 72 (61.5%)
no. of females 45 (38.5%)
Mean age 43.7 ± 19.46
Mean weight 53.6 ± 23.42
Abbreviation: icU, intensive care unit.Vascular Health and Risk Management 2009:5 647
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A survey of health care professionals in the West has 
shown that almost all of them recognize the importance of 
DVT prophylaxis, however only half of them implement 
current DVT prophylaxis strategies in real practice.15 Reasons 
that could play a role include concerns about an increased risk 
for bleeding from anticoagulants, lack of clear indications 
and contraindications for anticoagulant prophylaxis, and lack 
of time to consider VTE prophylaxis in every patient.16 Lack 
of awareness and concerns for cost of DVT prophylaxis in 
all critically ill patients could also be an important factor, 
particularly in developing countries such as India. We could 
not locate any literature to throw light on the reasons for lack 
of DVT prophylaxis in developing countries such as India 
and considerable work needs to be done to find out the actual 
hindrances in this regard.
In our study, a significant proportion of highest risk 
category patients (21.6%) died within their first two weeks 
of stay in hospital. Though the cause of death was not further 
looked into to document a confirmed DVT/PE, we clearly saw 
a statistically significant relation in mortality and high-risk 
predisposition for DVT. Detailed meta-analysis of all clinical 
trials to asses the efficacy of DVT prophylaxis in preventing 
adverse events like DVT/PE have shown a significant 
reduction (57% risk reduction) in risk for any PE.17 Thus 
clearly implementation of DVT prophylaxis strategies is the 
way to go to decrease the mortality and morbidity caused by 
events like PE in critically ill patients.
Various strategies have been used to increase VTE 
prophylaxis rates in medically ill patients. Studies have been 
done that show increase in DVT prophylaxis with strategies 
such as conducting educational programs to increase awareness 
for DVT prophylaxis18,19 and a computerized alert program 
for risk assessment and prophylaxis recommendation.20
Formulation and implementation of locally developed 
clinical guidelines has been shown to be beneficial in 
increasing the VTE prophylaxis rate and bringing down the 
rate of VTE episodes in individual hospital settings,21 and 
in general health care systems of other countries such as 
Italy.22 Presently we do not have any formalized guidelines, 
standardized order sets, alerting programs, training, or 
risk-stratification tools being used at our institution. This 
study highlights the importance of formulation of locally 
adapted clinical guidelines and their implementation in 
initial management of patients. Incorporation of risk assess-
ment and stratification score card for acutely ill patients as a 
part of their initial management as done in this study could 
be a simple and cost-effective way of identifying patients 
for DVT prophylaxis.
Limitations
Our small sample size of patients could be a limiting factor 
in predicting an actual prevalence of DVT and PE risk in 
acutely ill patients in our settings. No investigations were 
performed to document cases of clinically silent DVT. We did 
not follow up the patients after discharge or after two weeks 
of stay in hospital. Of the patients who died, we had not 
inquired into specific causes during their hospital stay so 
could not document PE as the cause of death.
Conclusion
A significant risk for DVT and PE exists in acutely ill 
patients admitted to wards and ICU, but only a small 
proportion of the patients are currently given prophylaxis 
or investigated. This may be responsible for the increased 
mortality and poor prognosis seen in patients with the 
highest risk for DVT and PE. This study underlines the 
need to aggressively implement DVT risk stratification 
strategy in medical patients and provide prophylaxis unless 
contraindicated. Successful programs like formulation 
of DVT prophylaxis guidelines, incorporation of risk 
assessment and stratification tools in routine patient workup, 
and interventions to increase awareness of DVT prophylaxis 
in health care professionals need to be implemented in our 
heath care system to improve VTE prophylaxis and decrease 
rates of VTE.
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